ATHE
Alteri Thera Sp ADS (ATHE)
NASDAQ
$4.12+$0.07 (+1.73%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $73.7M
    Market Cap
  • -17.01%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-17.6M
+22.39%
-14.4M
-22.74%
-18.6M
+41.26%
-13.2M
-10.49%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
10.5M
+92.07%
5.5M
+15.09%
4.8M
-5.81%
5.1M
-8.29%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-6,188
-14.26%
-7,217
+58.09%
-4,565
+99.78%
Interest Income and Expense and Net
0
+100.00%
-6,188
-14.26%
-7,217
+58.09%
-4,565
+99.78%
Total Nonoperating Income and Expense
3.6M
-52.76%
7.6M
+90.12%
4.0M
+2.63%
3.9M
-23.56%
Income before Taxes
-23.4M
+92.63%
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
Income Taxes
113,499
+66.78%
68,055
+47.66%
46,088
-55.88%
104,459
+49.21%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-23.4M
+92.63%
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
Net Income from Continuing Operations Applicable to Common
-23.4M
+92.63%
-12.1M
-36.48%
-19.1M
+38.51%
-13.8M
+7.47%
Basic EPS and Net Income
-11.12
+5,752.63%
-0.19
-63.46%
-0.52
-8.77%
-0.57
+7.55%
Diluted EPS and Net Income
-11.12
+5,752.63%
-0.19
-63.46%
-0.52
-8.77%
-0.57
+7.55%
Basic Weighted Average Shares
210.5M
-96.71%
6.4B
+75.31%
3.6B
+50.29%
2.4B
+0.91%
Diluted Weighted Average Shares
210.5M
-96.71%
6.4B
+75.31%
3.6B
+50.29%
2.4B
+0.91%
Balance Sheet
Cash and Cash Equivalents
37.3M
+12.54%
33.2M
+162.35%
12.6M
-19.87%
15.8M
-54.68%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
37.3M
+12.54%
33.2M
+162.35%
12.6M
-19.87%
15.8M
-54.68%
Total Current Assets
45.8M
-0.09%
45.9M
+140.96%
19.0M
-29.62%
27.0M
-34.26%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
302
-92.15%
3,848
-88.03%
32,154
-47.95%
61,776
-39.76%
Total Long-Term Assets
190,561
+22.80%
155,174
-16.97%
186,883
-30.49%
268,863
+23.04%
Total Assets
46.0M
-0.01%
46.0M
+139.42%
19.2M
-29.63%
27.3M
-33.96%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.2M
-10.71%
3.5M
-34.22%
5.4M
+22.63%
4.4M
-24.71%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
138,290
+56.18%
88,545
+70.56%
51,914
-57.69%
122,710
+66.70%
Total Liabilities
3.3M
-9.07%
3.6M
-33.22%
5.4M
+20.44%
4.5M
-23.57%
Retained Earnings
-245.6M
+8.72%
-225.9M
-205.48%
214.2M
+209.75%
-195.1M
+7.28%
Total Stockholders Equity
42.7M
+0.76%
42.4M
+207.31%
13.8M
-39.52%
22.8M
-35.68%
Total Shares Outstanding
217.5M
-97.62%
9.1B
+73.58%
5.3B
+115.52%
2.4B
+1.37%
Cash Flow
Cash from Operating Activities
-22.5M
+96.69%
-11.5M
-9.16%
-12.6M
-37.08%
-20.0M
+62.40%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
7.5M
+200.00%
-7.5M
+130,973.05%
-5,722
-84.31%
-36,461
-59.10%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
19.1M
-51.77%
39.7M
+330.43%
9.2M
+7,312.17%
124,340
-99.24%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-50.85%
+36.56%
-37.23%
-54.69%
-82.18%
+104.40%
-40.21%
+17.28%
Return on Equity
-54.98%
+27.18%
-43.23%
-58.62%
-104.47%
+120.50%
-47.38%
+21.59%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
14.52
+11.89%
12.98
+266.32%
3.54
-42.61%
6.17
-12.68%
Cash Ratio
11.82
+26.04%
9.38
+298.84%
2.35
-34.66%
3.60
-39.81%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow